Sequential blood level monitoring of basiliximab during multisession plasmapheresis in a kidney transplant recipient

Transplantation Proceedings

Volumn 37, Issue 2, 2005, Pages 875-878

  Nojima, M ^a   Yoshimoto, T ^a   Nakao, A ^a   Itahana, R ^a   Kyo, M ^b   Hashimoto, M ^c   Shima, H ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Sakurabashi Iseikai Clinic   (Japan)

^c Hyogo Prefectural Nishinomiya Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; TACROLIMUS;

ADULT; CASE REPORT; CONFERENCE PAPER; DRUG BLOOD LEVEL; FLOW CYTOMETRY; GRAFT REJECTION; HEMODIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL;

EID: 17844391848     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.01.050     Document Type: Conference Paper

References (7)

1. T. Haba, K. Uchida, A. Katayama Pharmacokinetics and pharmacodynamics of a chimeric interleukin-2 receptor monoclonal antibody, basiliximab, in renal transplantation: a comparison between Japanese and non-Japanese patients Transplant Proc 33 2001 3174
2. C. Aichberger, W. Nussbaumer, P. Rosmanith Plasmapheresis for the treatment of acute vascular rejection in renal transplantation Transplant Proc 29 1997 169
3. B.D. Kahan, P.R. Rajagopalan, M. Hall United States Simulect Renal Study Group Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2- receptor monoclonal antibody Transplantation 67 1999 276
4. J. Kovarik, T. Breidenbach, C. Gerbeau Disposition and immunodynamics of basiliximab in liver allograft recipients Clin Pharmacol Ther 64 1998 66
5. P.L. Amlot, E. Rawlings, O.N. Fernando Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation Transplantation 60 1995 748
6. C.N. Okechukwu, H.U. Meier-Kriesche, D. Armstrong Removal of basiliximab by plasmapheresis Am J Kidney Dis 37 2001 1
7. Y. Nakagawa, K. Saito, N. Kumagaya The clinical study of immunosuppression protocol with basiliximab (Simulect) and steroid withdrawal in renal transplantation Transplantat Now 16 2003 580